GC GLOBAL FUNDS CBTP PROJECT EXPLORING TUMOR INFLITRATION

WEILL CORNELL MEDICINE TEAM AWAREDED $100,000 GRANT TO ADVANCE RESEARCH IN GLIOMATOSIS CEREBRI 

Weill Cornell Medicine investigators have been awarded a $100,000, two-year grant from the GC Global consortium to advance research aimed at improving understanding of diffuse pediatric brain tumors, including gliomas that spread extensively through brain tissue and often referred to as gliomatosis cerebri (GC). 

This work brings together a multidisciplinary team of neurosurgeons, neuroradiologists, computational scientists, pathologists, and veterinary collaborators to address one of the most difficult challenges in neurooncology: how to meaningfully measure and understand tumor spread within the brain. At present, these tumors often extend beyond what can be seen on scans, making them difficult to classify, compare, and treat consistently across institutions. 

The project will develop standardized tools that integrate imaging, tissue analysis, and molecular data to better describe patterns of tumor infiltration. By creating a more consistent framework for how diffusely these tumors behave, researchers can improve how they compare cases and how clinicians understand disease progression over time. 

A unique aspect of this effort is the inclusion of naturally occurring brain tumors in canine patients, which closely mirror the diffuse behavior seen in children. This comparative approach is expected to strengthen the scientific framework and support future translational discoveries. 

Over the next two years, the team will validate these tools across large collaborative datasets and work toward producing resources that can be shared broadly with the research community, helping to advance a more unified approach to studying these complex tumors. 

We are deeply grateful to the philanthropic partners whose commitment helped make this work possible: 

  • The AYJ Fund  
  • Emma Hill  
  • The Joshua Bembo Foundation  
  • The Rudy A. Menon Foundation  
  • Yury Labintsev, on behalf of The Timon Labintsev Pediatric Brain Tumor Research Initiative  

Their support ensures that research into the most aggressive and least understood pediatric brain tumors continues with urgency and hope—bringing us closer to more precise understanding and, ultimately, better treatments for children and families facing these diseases.